HIGHLIGHTS
- who: Revised and collaborators from the Department of Biomedical Engineering, the City College of the City University of New York, New York, NY, USA have published the Article: Inhibition of Abl Kinase by Imatinib Can Rescue the Compromised Barrier Function of 22q11.2DS Patient-iPSC-Derived Blood-Brain Barriers, in the Journal: Cells 2023, 12, 422. of 26/04/2018
- what: The authors showed that imatinib, an inhibitor of Abl kinase, can rescue the deficits in the iBBBs of 22q11.2DS patients. The study provides much more detail on the molecular mechanism for understanding the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.